Airway hydration, apical K+ secretion, and the Large-conductance, Ca2+-activated and voltage-dependent potassium (BK) channel

Annals of the American Thoracic Society

Volumn 13, Issue , 2016, Pages S163-S168

  Kis, Adrian ^a   Krick, Stefanie ^a   Baumlin, Nathalie ^a   Salathe, Matthias ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Airway surface liquid; BK channels; Mucociliary clearance

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GAMMA INTERFERON; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; TRANSFORMING GROWTH FACTOR BETA1; VOLTAGE GATED POTASSIUM CHANNEL; LRRC26 PROTEIN, HUMAN; POTASSIUM; TUMOR PROTEIN;

CELL FUNCTION; CELL NUCLEUS MEMBRANE; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; DOWN REGULATION; GENETIC CODE; HUMAN; HYDRATION; LUNG FUNCTION; MITOCHONDRIAL MEMBRANE; NONHUMAN; POTASSIUM TRANSPORT; PROTEIN FUNCTION; PROTEIN STRUCTURE; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT DISEASE; METABOLISM; MUCOCILIARY CLEARANCE; RESPIRATORY MUCOSA;

HUMANS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MUCOCILIARY CLEARANCE; NEOPLASM PROTEINS; POTASSIUM; RESPIRATORY MUCOSA;

EID: 84989231095     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201507-405KV     Document Type: Conference Paper

References (44)

1. Rothberg BS. The BK channel: a vital link between cellular calcium and electrical signaling. Protein Cell 2012;3:883-892.
2. Zhang J, Yan J. Regulation of BK channels by auxiliary g subunits. Front Physiol 2014;5:401.
3. Kyle BD, Braun AP. The regulation of BK channel activity by pre- and post-translational modifications. Front Physiol 2014;5:316.
4. Magleby KL. Gating mechanism of BK (Slo1) channels: so near, yet so far. J Gen Physiol 2003;121:81-96.
5. Knowles MR, Boucher RC. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 2002;109:571-577.
6. Boucher RC. Regulation of airway surface liquid volume by human airway epithelia. Pflugers Arch 2003;445:495-498.
7. Lee US, Cui J. BK channel activation: structural and functional insights. Trends Neurosci 2010;33:415-423.
8. Sun X, Zaydman MA, Cui J. Regulation of voltage-activated K (+) channel gating by transmembrane b subunits. Front Pharmacol 2012;3:63.
9. Yan J, Aldrich RW. BK potassium channel modulation by leucine-rich repeat-containing proteins. Proc Natl Acad Sci USA 2012;109:7917-7922.
10. Yan J, Aldrich RW. LRRC26 auxiliary protein allows BK channel activation at resting voltage without calcium. Nature 2010;466:513-516.
11. Torres YP, Granados ST, Latorre R. Pharmacological consequences of the coexpression of BK channel a and auxiliary b subunits. Front Physiol 2014;5:383.
12. Bentzen BH, Olesen SP, Rønn LC, Grunnet M. BK channel activators and their therapeutic perspectives. Front Physiol 2014;5:389.
13. Semenov I, Wang B, Herlihy JT, Brenner R. BK channel b1 subunits regulate airway contraction secondary to M2 muscarinic acetylcholine receptor mediated depolarization. J Physiol 2011;589:1803-1817.
14. Matsui H, Grubb BR, Tarran R, Randell SH, Gatzy JT, Davis CW, Boucher RC. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998;95:1005-1015.
15. Boucher RC. An overview of the pathogenesis of cystic fibrosis lung disease. Adv Drug Deliv Rev 2002;54:1359-1371.
16. Button B, Cai LH, Ehre C, Kesimer M, Hill DB, Sheehan JK, Boucher RC, Rubinstein M. A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia. Science 2012;337:937-941.
17. Tarran R. Regulation of airway surface liquid volume and mucus transport by active ion transport. Proc Am Thorac Soc 2004;1:42-46.
18. Frizzell RA, Hanrahan JW. Physiology of epithelial chloride and fluid secretion. Cold Spring Harb Perspect Med 2012;2:a009563.
19. +-sensitive fluorescent dye. J Biol Chem 2009;284:15916-15926.
20. Manzanares D, Gonzalez C, Ivonnet P, Chen RS, Valencia-Gattas M, Conner GE, Larsson HP, Salathe M. Functional apical large conductance, Ca2+-activated, and voltage-dependent K+ channels are required for maintenance of airway surface liquid volume. J Biol Chem 2011;286:19830-19839.
21. Manzanares D, Srinivasan M, Salathe ST, Ivonnet P, Baumlin N, Dennis JS, Conner GE, Salathe M. IFN-γ-mediated reduction of largeconductance, Ca2+-activated, voltage-dependent K+ (BK) channel activity in airway epithelial cells leads to mucociliary dysfunction. Am J Physiol Lung Cell Mol Physiol 2014;306:L453-L462.
22. Manzanares D, Krick S, Baumlin N, Dennis JS, Tyrrell J, Tarran R, Salathe M. Airway surface dehydration by growth factor TGF-b in cystic fibrosis is due to decreased function of a voltage-dependent potassium channel and can be rescued by the drug pirfenidone. J Biol Chem 2015;290:25710-25716.
23. Guha A, Vasconcelos M, Zhao R, Gower AC, Rajagopal J, Cardoso WV. Analysis of Notch signaling-dependent gene expression in developing airways reveals diversity of Clara cells. PLoS One 2014;9:e88848.
24. Kent G, Iles R, Bear CE, Huan LJ, Griesenbach U, McKerlie C, Frndova H, Ackerley C, Gosselin D, Radzioch D, et al. Lung disease in mice with cystic fibrosis. J Clin Invest 1997;100:3060-3069.
25. Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O, Koller BH. An animal model for cystic fibrosis made by gene targeting. Science 1992;257:1083-1088.
26. Clarke LL, Grubb BR, Gabriel SE, Smithies O, Koller BH, Boucher RC. Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis. Science 1992;257:1125-1128.
27. Ostrowski LE, Yin W, Rogers TD, Busalacchi KB, Chua M, O'Neal WK, Grubb BR. Conditional deletion of dnaic1 in a murine model of primary ciliary dyskinesia causes chronic rhinosinusitis. Am J Respir Cell Mol Biol 2010;43:55-63.
28. Kumar RK, Yang M, Herbert C, Foster PS. Interferon-g, pulmonary macrophages and airway responsiveness in asthma. Inflamm Allergy Drug Targets 2012;11:292-297.
29. Kumar RK, Webb DC, Herbert C, Foster PS. Interferon-gamma as a possible target in chronic asthma. Inflamm Allergy Drug Targets 2006;5:253-256.
30. Kobayashi M, Ashino S, Shiohama Y, Wakita D, Kitamura H, Nishimura T. IFN-g elevates airway hyper-responsiveness via up-regulation of neurokinin A/neurokinin-2 receptor signaling in a severe asthma model. Eur J Immunol 2012;42:393-402.
31. Panzner P, Lafitte JJ, Tsicopoulos A, Hamid Q, Tulic MK. Marked up-regulation of T lymphocytes and expression of interleukin-9 in bronchial biopsies from patients with chronic bronchitis with obstruction. Chest 2003;124:1909-1915.
32. Tzanakis N, Chrysofakis G, Tsoumakidou M, Kyriakou D, Tsiligianni J, Bouros D, Siafakas NM. Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease. Respir Med 2004;98:57-65.
33. Harvey PR, Tarran R, Garoff S, Myerburg MM. Measurement of the airway surface liquid volume with simple light refraction microscopy. Am J Respir Cell Mol Biol 2011;45:592-599.
34. Zakharov SI, Morrow JP, Liu G, Yang L, Marx SO. Activation of the BK (SLO1) potassium channel by mallotoxin. J Biol Chem 2005;280:30882-30887.
35. Almassy J, Begenisich T. The LRRC26 protein selectively alters the efficacy of BK channel activators. Mol Pharmacol 2012;81:21-30.
36. Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, et al.; Gene Modifier Study Group. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 2005;353:1443-1453.
37. Arkwright PD, Pravica V, Geraghty PJ, Super M, Webb AK, Schwarz M, Hutchinson IV. End-organ dysfunction in cystic fibrosis: association with angiotensin I converting enzyme and cytokine gene polymorphisms. Am J Respir Crit Care Med 2003;167:384-389.
38. Arkwright PD, Laurie S, Super M, Pravica V, Schwarz MJ, Webb AK, Hutchinson IV. TGF-beta (1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax 2000;55:459-462.
39. Van Goor F, Hadida S, Grootenhuis PD, Burton B, Cao D, Neuberger T, Turnbull A, Singh A, Joubran J, Hazlewood A, et al. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc Natl Acad Sci USA 2009;106:18825-18830.
40. Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, Drȩvínek P, Griese M, McKone EF, Wainwright CE, Konstan MW, et al.; VX08-770-102 Study Group. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011;365:1663-1672.
41. Tricarico D, Mele A, Calzolaro S, Cannone G, Camerino GM, Dinardo MM, Latorre R, Conte Camerino D. Emerging role of calcium-activated potassium channel in the regulation of cell viability following potassium ions challenge in HEK293 cells and pharmacological modulation. PLoS One 2013;8:e69551.
42. Dinardo MM, Camerino G, Mele A, Latorre R, Conte Camerino D, Tricarico D. Splicing of the rSlo gene affects the molecular composition and drug response of Ca2+-activated K+ channels in skeletal muscle. PLoS One 2012;7:e40235.
43. Tricarico D, Barbieri M, Mele A, Carbonara G, Camerino DC. Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+-deficient rats. FASEB J 2004;18:760-761.
44. Foresi A, Cavigioli G, Pelucchi A, Mastropasqua B, Marazzini L. Effect of acetazolamide on cough induced by low-chloride-ion solutions in normal subjects: comparison with furosemide. J Allergy Clin Immunol 1996;97:1093-1099.